首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 93 毫秒
1.
Huang Y  Dai G  Feng Z  Lu C  Cheng B  Wang Q  Nie F  Li J 《中华医学杂志(英文版)》2003,116(11):1767-1769
Objective To investigate the effect of micronized fenofibrate on vascular endothelial function in patients with hypertriglyceridemia. Methods Using high-resolution ultrasound, we measured flow- and nitroglycerin-induced dilatation of the brachial artery in 30 patients with hypertriglyceridemia before and after treatment with micronized fenofibrate at a dose of 200 mg once daily for 4 weeks. Simultaneously, both serum lipid and plasma endothelin (ET) levels were determined.Results After micronized fenofibrate therapy, serum triglyceride (TG) levels decreased significantly (P<0.05). Plasma ET levels also decreased markedly [(82.66±15.46) μg/L vs. (106.22±19.16) μg/L, P<0.001]. Flow-induced vasodilatation was much improved (11.0%±9.0% vs 2.7%±2.0%, P<0.01). However, no significant changes in vasodilatation occurred in response to nitroglycerin (16.2%±6.0% vs 15.0%±5.0%, P>0.05) in patients with hypertriglyceridemia. Conclusions Micronized fenofibrate can improve impaired endothelium-dependent vasodilatation in patients with hypertriglyceridemia. Improving endothelial function may also be the mechanism responsible for the beneficial effects of micronized fenofibrate.  相似文献   

2.
Objective To investigate the relationships between the polymorphisms of estrogen receptor (ER) gene, bone mineral density (BMD) and bone biochemical markers in Chinese postmenopausal women. Methods BMD of lumbar spine and femoral neck were measured using dual-energy X-ray absorptiometry (DEXA)in 186 Chinese postmenopausal women. The PvuⅡ and XbaⅠ polymorphisms of the ER gene were detected using polymerase chain reaction (PCR). Bone biochemical markers, serum alkaline phosphatase, osteocalcin and pyridinoline were measured by ELISA. Results The femoral neck(FN) BMD (Z score) was higher in pp compared to Pp (-0.01±0.12 vs. -0.35±0.09, P<0.05) while lumbar spine BMD (Z score) was higher in XX type compared to Xx and xx genotypes (0.01±0.45 vs -1.53±0.17, -1.29±0.10, P<0.001 and 0.001, respectively). Women without Px haplotype (n=79) had a higher BMD Z-score for the lumbar spine (-1.03±0.14 vs -1.45±0.11, P<0.05) and femoral neck (-0.01±0.11 vs -0.31±0.09, P<0.05) than those who had it (n=107). Conclusions The present study suggested that the pp and XX genotypes of ER gene might play a certain role in maintaining FN and lumbar spine BMD. ER genotypes without Px haplotype might be favorable to bone mass, while those with it might exert some harmful effect on bone mineral density.  相似文献   

3.
Objective To investigate the possible bone changes in female patients with systemic lupus erythematosus (SLE) induced by long-term administration of Tripterygium Wilfordii Hook.F (TW). Methods 70 female SLE patients were divided into 4 groups accordiog to their drug history: SLE disease control group, corticosteroids treatment group, TW treatment group, and both corticosteroids and TW treatment group.Bone mineral density (BMD) of the lumbar spine 2-4 and biochemical markers of bone turnover were studied. Results Long-term administration of TW could significantly decrease BMD levels in female SLE patients (P<0.05).The patients receiving TW for more than 5 years had significantly lower BMD levels compared with those for less than 5 years.The degree of decreased BMD induced by TW was less severe compared with that of prednisone.No significant differences were observed in the biochemical markers of bone turnover among four groups (P>0.05). Conclusion Long-term administration of TW could decrease BMD levels in women.Osteoporosis may be an important problem for SLE patients treated with TW.  相似文献   

4.
Li Z  Liu F  Fu S  Qu R  Liu Z  Wu S 《中华医学杂志(英文版)》2003,116(8):1191-1193
Objective To investigate the effects of thoracic epidural blockade (TEB) on plasma fibrinogen (FIB) levels.Methods Thirty cases of dilated cardiomyopathy (DCM) were selected randomly into a TEB group and a control group. TEB patients were subjected to a persistent TEB (T1-5), and injected with 0.5% lidocaine 3-5 ml every two or four hours for four weeks in addition to routine medicine, while patients in the control group were given routine medicine only. Plasma concentrations of FIB were measured using the micro-capillary assay. Doppler echocardiography was performed before and after the treatment. Results Plasma concentrations of FIB in two groups were greater than the normal value before the treatment. There was a significant decrease of plasma concentrations of FIB in the TEB group after the treatment (4.2±1.3 g/L vs 3.6±0.9 g/L, P<0.05), but there was no significant change in the control group (4.2±1.2 g/L vs 4.3±1.9 g/L, P>0.05). After four weeks of treatment, the left ventricular end diastolic diameters (LVEDD) of TEB patients were reduced (72±10 mm vs 69±10 mm, P<0.05) and the left ventricular ejection fraction (LVEF) of TEB patients increased significantly (33%±13% vs 44%±14%, P<0.05). In contrast, LVEDD (73±11 mm vs 73±12 mm, P>0.05) and LVEF (32%±14% vs 33%±12%, P>0.05) did not change significantly in the control group. Conclusions The results suggest that plasma FIB levels in patients with DCM were decreased by performing a TEB, in addition to a reduction of the enlarged cardiac cavity and an improvement in cardiac systolic dysfunction. TEB might contribute to lowering the occurrence of thrombus and thromboembolism in patients with DCM. TEB might be a promising therapeutic method to improve the prognosis of DCM patients.  相似文献   

5.
Chen B  Wang W  Zhao H  Hu D  Xu C  Zhao M  Lu M  Liu J  Wu C 《中华医学杂志(英文版)》2003,116(1):142-144
Objective To compare the efficacy of low dose recombin ant tissue-type plasminogen activator (rt-PA) thrombolysis with primary corona ry stenting after acute myocardial infarction. Methods Of 261 patients with first acute myocardial i nfarction, 131 were given low dose rt-PA intravenous thrombolysis, and 130 primary coronary stenting. Results The age, time from onset of chest pain to hosp ital presentation and infarct location between these two groups were comparable . The patency rate of the infarct-related artery (IRA) in patients in the thro mbolysis group was significantly lower than that of patients in the primary sten ting group (P<0.001). Recurrent myocardial infarction, and selective coron ary stenting of patients with thrombolytic therapy were higher than that of pat ients in the primary stenting group (7.6% vs 1.5%, P<0.05; 20.6% vs 0, P<0.001, respectively). Left ventricular ejection fraction (LVEF) in patie nts in the thrombolysis group was lower than that of the stent group (55.6%±13 .4% vs 65.8%±9.2%, P<0.001). Total hospitalization time of the thrombo lysis group was longer than that of the stent group (16±7 d vs 11±4 d, P <0.001). Mortality in the thrombolysis group was higher than that of the stent group, but this difference was not significant (6.1% vs 3.1%,P>0 .05) Conclusion Comparing with low dose rt-PA thrombolytic therapy after acute myocardial infarction, primary coronary stenting has a highe r patency rate of the IRA, better cardiac function and shorter hospitalization time.  相似文献   

6.
Objective To explore the effects of thyroid hormone (TH) on cardiac function and peripheral lymphocyte β-adrenoceptors (β-ARs) of patients with chronic congestive heart failure (CHF). Methods Twenty-eight patients with class Ⅲ or Ⅳ advanced CHF due to dilated cardiomyopathy (DCM) or ischemic cardiomyopathy (ICM) were randomly divided into groups A and B. L-thyroxine (L-T50) was administered to group B. Exercise tolerance, chest X-rays, and echocardiographic parameters were obtained before and after one month of treatment, Ficoll-hypaque solution was used to separate peripheral lymphocytes, and 125I-pindolol radioligand binding was used to measure β-AR levels in peripheral lymphocytes. Results L-T50 therapy improved cardiac output [CO, (2.98±0.31)L/min vs (3.24±0.28) L/min, P<0.01], left ventricular ejection fraction (LVEF, 26.21%±3.21% vs 37.93%±9.01%, P<0.01), and decreased isovolumetric relaxation time (IVRT, 0.12±0.04 vs 0.10±0.02, P<0.01). Serum TH levels and the maximal number of β-AR binding sites (βmax ) in peripheral lymphocytes were lower in patients with CHF than in normal healthy people, but L-T50 administration induced a β-AR up-regulation on peripheral lymphocyte surfaces. L-T50 was well tolerated without episodes of ischemia or arrhythmia. There was no significant change in heart rate or metabolic rate. Conclusion TH administration improves cardiac function and β-AR expression in peripheral lymphocytes of patients with CHF.  相似文献   

7.
8.
Hu K  Li Q  Yang J  Hu S  Chen X 《中华医学杂志(英文版)》2003,116(11):1711-1716
Objective To determine the prevalence of sleep-disordered breathing in patients with stable, optimally treated chronic congestive heart failure and the effect of short-term oral theophylline therapy on periodic breathing in these patients.Methods Patients with stable, optimally treated chronic congestive heart failure were monitored by polysomnography during nocturnal sleep. The effects of theophylline therapy on periodic breathing associated with stable heart failure were observed before and after treatment.Results Patients were divided into two groups. GroupⅠ(n=21) consisted of individuals with 15 episodes of apnea and hypopnea [as determined by the apnea-hypopnea index (AHI)] per hour or less; Group Ⅱ (n=15, 41.7%) individuals had an index of more than 15 episodes per hour. In group Ⅱ, the AHI varied from 16.8 to 78.8 (42.6±15.5) in which the obstructive AHI was 11.1±8.4 and the central AHI was 31.5±9.6. Group Ⅱ had significantly more arousals (36.8±21.3 compared with 19.4±11.2 in group Ⅰ) that were directly attributable to episodes of apnea and hypopnea, lower arterial oxyhemoglobin saturation (76.7%±4.6% compared with 86.5%±2.8%) and lower left ventricular ejection fraction (24.2%±8.8% compared with 31.5%±10.6%). Thirteen patients with compensated heart failure and periodic breathing received theophylline orally (at an average dose of 4.3 mg/kg) for five to seven days. After treatment, the mean plasma theophylline concentration was (11.3±2.5) μg/ml. Theophylline therapy resulted in significant decreases in the number of AHI (20.8±13.2 vs. 42.6±15.5; P<0.001) and the number of episodes of central apnea-hypopnea per hour (10.1±7.6 vs. 31.5±9.6; P<0.001). Furthermore, the percentage of total sleep time during which arterial oxyhemoglobin saturation (SaO2) was less than 90 percent (8.8%±8.6% vs. 23.4%±24.1%; P<0.05) and the arousals per hour (18.7±21.2 vs. 36.8±21.3; P<0.05) were also lower. There were no significant differences in the characteristics of sleep or obstructive AHI before and after theophylline treatment.Conclusions The prevalence of sleep-disordered breathing (mainly periodic respiration or cheyne-stokes respiration with central sleep apnea) is high in patients with stable chronic congestive heart failure. The sleep-disordered breathing episodes are associated with severe nocturnal arterial blood oxyhemoglobin desaturation and excessive arousals. In these patients, oral theophylline therapy may reduce the number of episodes of central apnea and hypopnea and the duration of arterial oxyhemoglobin desaturation during nocturnal sleep.  相似文献   

9.
Objective To evaluate the safety and analgesic efficacy of patient controlled intravenous analgesia (PCIA) with tramadol, and to compare its benefits and risks with combined spinal-epidural analgesia (CSEA)+ patient controlled epidural analgesia (PCEA). Methods Eighty American Society of Anesthesiologist (ASA) Ⅰ-Ⅱ at term parturients in active labor were randomly divided into 3 groups: the control group (n=30) received no analgesia; group A (n=30) received spinal administration with ropivacaine 2.5 mg and fentanyl 5 μg, then with PCEA; group B (n=20) received 1 mg/kg tramadol loading dose i.v.. PCIA with 0.75% tramadol and it included: PCA dose 2 ml, lockout time 10 minutes, background infusion 2 ml/h, total dose no more than 400 mg. The intensity of pain was evaluated using Visual Analogue Scale (VAS). Results Both group A and B showed good pain relief. VAS pain scores were significantly decreased in group A and B compared with those in the control group (P<0.01). In comparison with group B, the VAS pain scores decreased in group A (P<0.05). The onset times of analgesia in group A were shorter than those in group B (P<0.05). Apgar scores in group B were lower than those in group A (P<0.05). The periods of second stage of labor in group A were longer than those in the control group and group B (P<0.05). The cesarean delivery rate was significantly higher in the control group (16.7%) than in group A (3.3%) and group B (5.0%), but it did not differ between group A and B. There were no significant differences in vital signs, fetal heart rate, degree of motor block, and uterine contractions among the 3 groups. Conclusions PCIA with tramadol is now a useful alternative when patients are not candidates for CSEA for labor, or do not want to have a neuraxial block anesthesia. However, sometimes it may not provide satisfactory analgesic effect.  相似文献   

10.
Objective To evaluate the change in D(2) receptors and their relationship with dopamine (DA) content in experimental hemi-parkinsonism rats before and after electro-acupuncture (EA) treatment. Methods (125) Ⅰ-IBZM D(2) receptor cerebral autoradio-graphic analysis, HPLC-ECD detection of DA and its metabolites, homovanillic acid (HVA), 3,4-dihydroxyphenylacetic acid (DOPAC) were used to study their levels in striatum in pre-EA, EA and EA control group. Results The DA, HVA and DOPAC levels in striatum of the lesioned side in the EA group were elevated compared to the pre-EA and EA control group (P<0.05). For the EA group, the striatum/cerebellum (125) Ⅰ-IBZM uptake ratio of the lesioned side was 8.04±0.71, (29.34%±4.83%) more than that of the contralateral side (P<0.05), while no significant difference was observed as compared with that in the pre-EA group (8.09±0.52, 30.12%±4.53%, higher than that of the intact side P>0.05). It was lower than the EA control group (8.61±0.63, P<0.05), and the latter was (38.63%±3.71%) higher than that in its contralateral side (P<0.05). Conclusion 6-OH-DA lesions in the substantia nigra and ventral tegmental areas induce an up-regulation of striatal D(2) binding sites. EA treatment could elevate the DA level of the lesioned side striatum and prevent D(2) receptor up-regulation in rats with experimental hemi-parkinsonism.  相似文献   

11.
目的 观察脱氢表雄酮硫酸酯治疗男性骨质疏松症的疗效、安全性。方法 随机单盲对照观察脱氢表雄酮硫酸酯 (DHEAS)服用六个月前后骨密度 (BMD)、血生化指标、骨吸收指标和骨形成指标 ,副作用等方面的变化。结果 治疗后治疗组脱氢表雄酮硫酸酯 (DHEAS)、类胰岛素生长因子 Ⅰ (IGF Ⅰ )较治疗前分别提高 (93 75±16 1) %、(17 71± 4 2 ) % ,较对照组明显提高 (P <0 0 1)。腰 2、腰 3、腰 4的骨密度 (BMD)较治疗前分别提高(2 6 5± 0 6 2 ) %、(2 70± 0 4 8) %、(3 10± 0 4 1) % ,腰 2 - 4较治疗前提高 (2 82± 0 37) % ,股骨颈的BND较治疗前提高 (2 32± 0 32 ) %。腰 2、腰 3、腰 4、腰 2 4、股骨颈的BMD上升幅度较大与对照组差别有显著性 (P <0 0 5 ,0 0 1)。游离睾丸酮 (FT)、雌二醇 (E2 )、前列特异抗原 (PSA)则无明显影响。结论 脱氢表雄酮硫酸酯治疗男性骨质疏松症的疗效安全可靠 ,无不良反应。  相似文献   

12.
目的 观察脱氢表雄酮硫酸酯治疗男性骨质疏松症的疗效、安全性. 方法 随机单盲对照观察脱氢表雄酮硫酸酯(DHEAS)服用六个月前后骨密度(BMD)、血生化指标、骨吸收指标和骨形成指标,副作用等方面的变化.结果 治疗后治疗组脱氢表雄酮硫酸酯(DHEAS)、类胰岛素生长因子-Ⅰ(IGF-Ⅰ)较治疗前分别提高(93.75±16.1)%、(17.71±4.2)%,较对照组明显提高(P<0.01).腰2、腰3、腰4的骨密度(BMD)较治疗前分别提高(2.65±0.62)%、(2.70±0.48)%、(3.10±0.41)%,腰2-4较治疗前提高(2.82±0.37)%,股骨颈的BND较治疗前提高(2.32±0.32)%.腰2、腰3、腰4、腰2-4、股骨颈的BMD上升幅度较大与对照组差别有显著性(P<0.05 ,0.01).游离睾丸酮(FT)、雌二醇(E2)、前列特异抗原(PSA)则无明显影响. 结论 脱氢表雄酮硫酸酯治疗男性骨质疏松症的疗效安全可靠,无不良反应.  相似文献   

13.
目的::探讨脱氢表雄酮( DHEA)在卵巢储备功能低下( DOR)不孕症患者中的治疗效果。方法:30例DOR不孕症患者连续3个月DHEA治疗。比较其治疗前后各项储备指标的变化,观察治疗后诱发排卵率、临床妊娠率、流产率等。结果:患者服用DHEA 3个月后,月经周期第3天卵泡刺激素、卵泡刺激素/黄体生成素、雌二醇均较治疗前明显下降(P<0.01),窦卵泡计数明显增加(P<0.01);诱发排卵成功24例,排卵率达80.00%;11例成功妊娠,累积妊娠率达45.83%,其中2例患者孕2个月流产,流产率18.18%。结论:DHEA能改善DOR患者卵巢储备功能,增加患者对促排卵药物的敏感性,诱发排卵成功率高,卵子质量也相应提高,能获得较好的临床妊娠率,且不良反应小。  相似文献   

14.
目的 初步探讨硫酸脱氢表雄酮(DHEAS)促进MIN6细胞胰岛素分泌的机制.方法 选用小鼠胰岛B细胞株MIN6作为实验对象,在葡萄糖浓度为2.8 mmol/L和16.7 mmol/L的条件下,分别以0.1、1、5、10、50μmol/L的DHEAS干预10 min和24h,采用ELISA法测定细胞培养上清液中胰岛素的含量,应用相关试剂盒检测细胞内三磷酸腺苷(ATP)和二磷酸腺苷(ADP)的生物发光水平及比率(ATP/ADP);采用Real-Time PCR法检测不同浓度DHEAS干预24 h的细胞内葡萄糖激酶(GCK) mRNA的表达.结果 两种葡萄糖浓度条件下,以5、10、50 μmol/L DHEAS干预10 min和24 h的MIN6的细胞培养上清液中胰岛素含量和细胞内ATP/ADP比率显著高于空白对照组(P<0.05).与空白对照组比较,1、5、10、50 μmol/L DHEAS干预24 h的MIN6细胞内GCK mRNA表达显著上调(p<0.05).结论 DHEAS可能通过增加ATP/ADP的比率,促进MIN6细胞胰岛素的分泌;干预24 h的效应可能与上调GCK mRNA的表达、促进葡萄糖酵解有关.  相似文献   

15.
目的 探讨多囊卵巢综合征(PCOS)患者血清硫酸脱氢表雄酮(DHEA)、抗缪勒管激素(AMH)、 性激素结合球蛋白(SHBG)水平及经炔雌醇环丙孕酮片联合二甲双胍治疗后的变化。方法 选取2018 年 12 月—2019 年10 月在重庆三峡中心医院妇产科就诊的PCOS 患者52 例作为观察组。另取同期有规律月经 周期、卵巢功能正常的育龄期女性55 例作为对照组。观察组应用炔雌醇环丙孕酮片联合二甲双胍治疗,疗程 3 个月。比较两组治疗前血清DHEA、AMH 及SHBG 水平和观察组治疗前后血清DHEA、AMH 及SHBG 水平。采用Pearson 法分析血清DHEA、AMH、SHBG 与PCOS 病情严重程度的关系。结果 观察组治疗前 DHEA、AMH 较对照组高(P <0.05),SHBG 较对照组低(P <0.05)。1 型组治疗前血清DHEA、AMH 水平 高于3 型组、4 型组(P <0.05),SHBG 水平低于3 型组、4 型组(P <0.05),2 型组患者治疗前血清DHEA、 AMH 水平高于4 型组(P <0.05),SHBG 水平低于4 型组(P <0.05)。血清DHEA、AMH 与PCOS 病情严 重程度呈正相关(r =0.827 和0.764,P <0.05),SHBG 与PCOS 病情严重程度呈负相关(r =-0.852,P <0.05)。 观察组治疗后血清DHEA、AMH 较治疗前低(P <0.05),SHBG 较治疗前高(P <0.05)。结论 PCOS 患者 血清DHEA、AMH 水平升高,SHBG 水平降低。血清DHEA、AMH 及SHBG 均能有效反映PCOS 患者的病 情严重程度。炔雌醇环丙孕酮片联合二甲双胍对PCOS 患者具有良好的疗效,能有效改善患者血清DHEA、 AMH 及SHBG 水平。  相似文献   

16.
目的探究重组人生长激素(r-hGH)联合脱氢表雄酮(DHEA)对卵巢低反应(POR)小鼠模型干预效果及对生长分化因子-9(GDF-9)、晚期糖基化终末产物(AGE)及其受体(RAGE)的影响。方法100只小鼠随机分为对照组、模型组、r-hGH组、DHEA组和r-hGH+DHEA组。使用慢性制动应激法建立卵巢早衰及卵巢低反应小鼠模型,对照组用等量的溶剂处理。r-hGH组和DHEA组分别使用r-hGH和DHEA干预,r-hGH+DHEA组进行联合干预。检测血清抗苗勒管激素(AMH)水平。使用HE染色法检测卵巢中卵泡数量。qRT-PCR和Western blotting检测卵巢组织中AGE、RAGE和卵泡中GDF-9 mRNA和蛋白水平。结果建模后,小鼠血清AMH、卵泡数目以及GDF-9 mRNA和蛋白水平降低,而AGE、RAGE mRNA和蛋白水平升高(P<0.05)。r-hGH组和DHEA组的AMH、卵泡数目以及GDF-9 mRNA和蛋白水平高于模型组,而AGE、RAGE mRNA和蛋白水平低于模型组(P<0.05)。r-hGH+DHEA组AMH、卵泡数目以及GDF-9 mRNA和蛋白水平高于r-hGH组和DHEA组,而AGE、RAGE mRNA和蛋白水平低于r-hGH组和DHEA组(P<0.05)。结论r-hGH联合DHEA对POR小鼠具有较好干预效果,与下调卵巢中AGE、RAGE并促进GDF-9 mRNA和蛋白的表达有关。  相似文献   

17.
Background  Dehydroepiandrosterone (DHEA) is widely known for its beneficial effect on postmenopausal osteoporosis, although the underlying mechanisms remain mainly unclear. In this study, we tried to determine the activation of mitogen-activated protein kinase signal pathways during DHEA treatment and the indirect role of osteoblasts (OBs) on osteoclasts under the DHEA treatment of postmenopausal osteoporosis.
Methods  Primary human OBs and osteoclast-like cells were cultured and, we pretreated OBs with or without U0126 (a highly selective inhibitor of both MEK1 and MEK2). The OBs were treated with DHEA. We then tested the effects of DHEA on human osteoblastic viability, osteoprotegerin production and the expression of phosphor-ERK1/2 (extracellular signal-regulated kinase). In the presence or absence of OBs, the function of osteoclastic resorption upon DHEA treatment was calculated.
Results  DHEA promoted the human osteoblastic proliferation and inhibited the osteoblastic apoptosis within the concentration range of 10-8–10-6 mol/L (P <0.05, P <0.01, respectively). Within the effective concentration range, the expression of phosphor-ERK1/2 and osteoprotegerin was increased by DHEA and blocked by U0126. In the presence of OBs, DHEA could significantly decrease the number and the area of bone resorption lacuna (P <0.05 and P <0.01, respectively). Without OBs, however, the effects of DHEA on the bone resorption lacuna were almost completely abolished.

Conclusions  DHEA could indirectly inhibit the human osteoclastic resorption through promoting the osteoblastic viability and osteoprotegerin production, which is mediated by mitogen-activated protein kinases signal pathway involving the phosphor-ERK1/2.

  相似文献   

18.
目的 探讨绝经前后妇女去氢表雄酮(DHEA)水平与动脉粥样硬化的关系.方法 选取绝经前后健康妇女各40名,分为两组,观察各组颈动脉内膜中层厚度(IMT)和DHEA浓度,并测定了血脂、雌二醇、内皮素、E-选择素.结果 绝经后组颈动脉IMT增加,DHEA、雌二醇水平降低,IMT与DHEA显著相关,同时绝经后组内皮保护能力下降,而低密度脂蛋白水平升高.结论 女性低DHEA水平易引起动脉粥样硬化,这可能与低DHEA状态引起内皮保护能力下降和血脂升高有关.  相似文献   

19.
[目的]观察补肾调冲方与脱氢表雄酮(DHEA)治疗卵巢储备功能降低(DOR)所致不孕症患者的临床疗效。[方法]将60例DOR所致不孕症的患者随机分为3组,即补肾调冲方组、DHEA组、安慰剂组,均治疗3个月经周期。[结果]补肾调冲方可显著改善DOR患者临床症状、血清性激素水平及四清抗苗勒氏管激素(AMH)、抑制素B(INHB)值,增加卵巢窦卵泡数(AFC),提高卵巢储备功能,其疗效优于DHEA,差异有统计学意义(P0.05)。[结论]补肾调冲方在治疗因DOR所导致不孕症方面较DHEA疗效显著,且未发现有明显的毒副作用和不良反应,值得临床推广应用。  相似文献   

20.
目的探讨补充脱氢表雄酮对卵巢储备功能降低患者卵巢功能及IVF—ET妊娠结局的影响。方法选择89例进行IVF/ICSI—ET的DOR患者进行随机对照研究,对照组为未服用DHEA的患者(n=47)。研究组(n=42)患者口服DHEA75mg/d,3个月后接受IVF—ET周期。分析比较研究组患者服用DHEA前后卵巢储备功能指标(基础卵泡数、基础内分泌水平等);同时比较两组患者IVF周期治疗参数(获卵数、受精率、卵裂率、胚胎种植率、周期取消率、临床妊娠率、流产率等)的变化。结果研究组用药后FSH值较前下降(P〈0.05),窦卵泡数较前增加(P〈0.05);DHEA预治疗组较对照组基础卵泡计数、获卵数较对照组均显著增加(P〈0.05),促排周期中Gn总量明显低于对照组(P〈0.05),胚胎种植率、临床妊娠率呈提高趋势(P〉0.05),周期取消率呈降低趋势(P〉0.05),而卵裂率、受精率、流产率无差异(P〉0.05)。结论对卵巢储备功能降低患者补充DHEA能有效改善其卵巢储备功能,提高卵巢反应性,增加促排卵效果,进而提高IVF—ET的临床妊娠率。  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号